FDA approves pembrolizumab with chemotherapy for platinum-resistant ovarian cancer, showing significant survival benefits in ...

Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...

Chemotherapy uses medicines to kill fast-growing cells (like cancer cells) or to keep them from dividing (which is how cancers grow). It is a systemic treatment. This means the medicines will travel ...

"Therapy for small, node-negative, HER2-positive breast cancer can be challenging due to the risk of overtreatment. Our study can help assess outcomes of patients according to specific tumor sizes and ...

DOCTOR, SEVERAL NEW TREATMENTS ARE REVOLUTIONIZING THE FIGHT AGAINST BREAST CANCER AND CHIEF OF MEDICAL ONCOLOGY AT MERCY MEDICAL CENTER, DOCTOR DAVID REISBERG IS JOINING US NOW WITH SOME MORE ...

Chemotherapy remains one of the most powerful tools in the fight against cancer, yet it often comes with significant ...

The FDA has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneous, chemo-free treatment for patients with EGFR-mutated non-small cell lung cancer across all ...

New cancer research pioneered by Memorial Sloan Kettering points to a strong alternative to chemotherapy, surgery and radiation for some forms of cancer. Nearly 80% of patients who suffered from a ...

Good news for a grave concern. Researchers believe a groundbreaking new drug can offer hope to those diagnosed with this deadly breast cancer, creating a new standard of care and improved survival ...